Yahoo Search Busca da Web

Entrar

Resultado da Busca

  1. de.wikipedia.org › wiki › Derrick_RossiDerrick Rossi – Wikipedia

    Derrick Rossi (2008) Derrick J. Rossi (* 5.Februar 1966) ist ein in den USA lebender kanadischer Zellbiologe und Unternehmer.Er gründete unter anderem das Biotechnologieunternehmen Moderna und ist derzeit CEO von Convelo Therapeutics.

  2. www.yahoo.com › tech › founder-moderna-doesn-t-thinkThe founder of Moderna doesn’t think vaccines are all that ...

    30 de abr. de 2021 · Derrick Rossi doesn’t quite see it this way, but he kind of saved the world.. In 2008, he began researching messenger RNA (mRNA), building on the long-ignored work of Hungarian researcher ...

  3. www.cbc.ca › radio › checkupUsing mRNA to develop vaccines wasn't 'on my radar,' says ...

    23 de nov. de 2020 · In 2008, stem cell biologist Derrick Rossi discovered that modified messenger RNA, or mRNA as it's more commonly known, can prompt the body to quickly produce proteins that trigger an immune response.

  4. www.theguardian.com › science › 2020Covid vaccine technology pioneer: 'I never doubted it would ...

    21 de nov. de 2020 · Meanwhile, Rossi, a Canadian stem cell biologist who had read their groundbreaking 2005 paper, found strong financial backers and in 2010 founded Moderna in Cambridge, Massachusetts.

  5. www.linkedin.com › in › derrick-rossiDerrick Rossi - Castle Rock Entertainment | LinkedIn

    Dr. Rossi is a serial biotech entrepreneur and stem cell scientist. His efforts in the… · Experience: Castle Rock Entertainment · Education: University of Helsinki · Location: Newton Centre ...

    • Castle Rock Entertainment

  6. www.newswise.com › articles › the-new-york-stem-cellThe New York Stem Cell Foundation Names Dr. Derrick Rossi as ...

    24 de out. de 2022 · In 2010, Dr. Rossi was named a NYSCF – Robertson Stem Cell Investigator as a member of the inaugural class of Investigators for his discovery that induced pluripotent stem cells could be created ...

  7. pubmed.ncbi.nlm.nih.gov › 20888316Highly efficient reprogramming to pluripotency and directed ...

    5 de nov. de 2010 · Clinical application of induced pluripotent stem cells (iPSCs) is limited by the low efficiency of iPSC derivation and the fact that most protocols modify the genome to effect cellular reprogramming. Moreover, safe and effective means of directing the fate of patient-specific iPSCs toward clinically …